Key Segments:
By Product
-
Consumables
-
Instruments
-
Software
By Technology
-
Polymerase Chain Reaction
-
Capillary Electrophoresis
-
Next-generation Sequencing
-
Microarrays
-
Rapid DNA Analysis
By Application
-
Forensics
-
Paternity Testing
-
Other Applications
By End User
-
Forensic Laboratories
-
Research Centers and Academic & Government Institutes
-
Other End Users
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Thermo Fisher Scientific, QIAGEN, Promega, Illumina, Agilent Technologies, Bio-Rad Laboratories, ANDE Corporation, and Bode Technology.
Key opportunities include rapid DNA expansion, genetic genealogy database integration, emerging-market forensic infrastructure development, and software-driven mixture interpretation.
The market is driven by rising forensic DNA database expansion, rapid DNA adoption, quality assurance standard updates, and genetic genealogy applications.
The Consumables segment dominated the Human Identification Market, accounting for approximately 54% market share.
The North America region dominated the Human Identification Market in 2025 with approximately 41.0% share, driven by advanced infrastructure and substantial national DNA database investment.